|
|
Home > Health
Conditions > Lymphoma
Non-Hodgkin's Lymphoma
Popular Supplements:
Alternative News:
-
Sulforaphane Exhibits
Cytotoxic Effects against Primary Effusion Lymphoma Cells by Suppressing p38MAPK
and AKT Phosphorylation - Biol Pharm Bull. 2019;42(12):2109-2112 -
"Primary effusion lymphoma (PEL) ... Sulforaphane (SFN),
a natural compound found in cruciferous vegetables and broccoli sprouts,
modulates signaling pathways and epigenetic gene expression ... Our data and
previous literature indicate that SFN represses the phosphorylation of p38MAPK
and AKT, which results in PEL cell apoptosis" - See
sulforaphane at Amazon.com.
-
Improved Survival in
Cancer Patients With High Vitamin D - Medscape, 5/1/14 -
"overall survival for colorectal and breast cancer
patients in the highest quartile of circulating 25-hydroxyvitamin D
[25(OH)D] levels was significantly better than it was for those in the
lowest quartile of 25(OH)D levels ... Overall survival was also
significantly better for lymphoma patients in the highest 25(OH)D quartile
compared with those in the lowest quartile ... Considering that vitamin D
deficiency is widespread around the world, our suggestion is to ensure
everyone has sufficient levels of this important nutrient — that is,
circulating 25(OH)D levels — greater than 75 nmol/L ... when investigators
compared 25(OH)D levels in the range of 40 to 70 nmol/L to levels <19 nmol/L,
they found that a 10-nmol/L increase in circulating vitamin D levels upon
cancer diagnosis was associated with a 4% reduction in all-cause mortality
among all cancer patients in whom a dose-response relationship was assessed"
- See
vitamin D at Amazon.com.
-
Omega 3
fatty acids increase the chemo-sensitivity of B-CLL-derived cell lines EHEB
and MEC-2 and of B-PLL-derived cell line JVM-2 to anti-cancer drugs
doxorubicin, vincristine and fludarabine - Lipids Health Dis. 2013 Mar
16;12(1):36 - "N-3's are promising chemo-sensitizing
agents for the treatment of CLL. Selective enhancement of chemo-sensitivity
of EHEB, JVM-2 and MEC-2 to drugs by n-3 that is not dependent on increased
lipid peroxidation and ROS generation indicates alternative mechanisms by
which n-3 enhances chemo-sensitivity" - See
Mega Twin EPA at Amazon.com
and
Jarrow Max DHA at Amazon.com.
-
trans
Fatty Acid Intake Is Associated with Increased Risk and n3 Fatty Acid Intake
with Reduced Risk of Non-Hodgkin Lymphoma - J Nutr. 2013 Mar 13 -
"diets high in TFAs, processed meats, and higher fat
dairy products were positively associated with NHL risk, whereas diets high
in n3 fatty acids and total seafood were inversely associated with risk"
- See
Mega Twin EPA at Amazon.com
and
Jarrow Max DHA at Amazon.com.
-
Fruits
and vegetables consumption and risk of non-Hodgkin's lymphoma: A
meta-analysis of observational studies - Int J Cancer. 2012 Dec 13 -
"searched on PubMed database from January 1966
through September 2012 to indentify case-control and cohort studies ... For
vegetables, the summary relative risks (RRs) of NHL for high vs low intake
for case-control, cohort and all studies were 0.75 (95% CI, 0.60-0.94; N=8),
0.90 (95% CI, 0.81-1.00; N=5) and 0.81 (95%CI, 0.71-0.92; N=13) ; and the
corresponding RRs for intake of 1 serving per day were 0.88 (95% CI,
0.80-0.96; N=8), 0.96 (95% CI, 0.92-1.00; N=5) and 0.92 (95%CI, 0.87-0.96;
N=13). For fruits and vegetables combined, the summary RR for high vs low
intake was 0.78 (95%CI, 0.66-0.92; N=4), and for intake of 1 serving per day
was 0.95 (95%CI, 0.91-1.00; N=4) ... Fruits intake was generally not
associated with total NHL, or any histological subtypes. Our findings
suggest that intakes of vegetables, and fruits and vegetables combined, but
not fruits alone, significantly reduce risk of NHL"
-
Insufficient vitamin D levels in chronic lymphocytic leukemia patients
linked to cancer progression and death - Science Daily, 11/3/10 -
"patients with insufficient levels of vitamin D when
their leukemia was diagnosed progressed much faster and were about twice as
likely to die as were patients with adequate levels of vitamin D ... They
also found solid trends: increasing vitamin D levels across patients matched
longer survival times and decreasing levels matched shortening intervals
between diagnosis and cancer progression ... Other studies have suggested
that low vitamin D levels at diagnosis may be associated with poorer
outcomes in colorectal, breast, melanoma and lung cancers, as well as
lymphoma ... Vitamin D insufficiency, in general, is widespread" -
See
vitamin D at Amazon.com.
-
Vitamin D
Insufficiency and Prognosis in Non-Hodgkin's Lymphoma - J Clin Oncol. 2010
Aug 16 - "event-free survival (EFS) and overall survival
(OS) ... 25(OH)D insufficient patients with diffuse large B-cell lymphoma
(DLBCL) had inferior EFS (hazard ratio [HR], 1.41; 95% CI, 0.98 to 2.04) and OS
(HR, 1.99; 95% CI, 1.27 to 3.13); 25(OH)D insufficient patients with T-cell
lymphoma also had inferior EFS (HR, 1.94; 95% CI, 1.04 to 3.61) and OS (HR,
2.38; 95% CI, 1.04 to 5.41). There were no associations with EFS for the other
NHL subtypes. Among patients with DLBCL and T-cell lymphoma, higher 1,25(OH)(2)D
levels were associated with better EFS and OS, suggesting that any putative
tumor 1-alpha-hydroxylase activity did not explain the 25(OH)D associations.
CONCLUSION 25(OH)D insufficiency was associated with inferior EFS and OS in
DLBCL and T-cell lymphoma. Whether normalizing vitamin D levels in these
patients improves outcomes will require testing in future trials" - See
vitamin D at Amazon.com.
-
Vitamin K may cut lymph cancer risk: US study - Nutra USA, 4/21/10
-
Vitamin K may protect against developing non-Hodgkin's lymphoma, say Mayo
Clinic researchers - Science Daily, 4/19/10 -
"the risk of developing Non-Hodgkin lymphoma was approximately 45 percent
lower for participants who had vitamin K intakes in the top quartile of
intake in the study (>108 ug/day), compared to participants who had intakes
in the bottom quartile (<39 ug/day). This association remained after
accounting for other factors such as age, sex, education, obesity, smoking,
alcohol use and intake of foods with high amounts of antioxidants"
-
Vitamin D May Boost Lymphoma Survival - WebMD, 12/7/09
-
Vitamin D levels associated with survival in lymphoma patients - Science
Daily, 12/5/09 - "Patients with deficient vitamin D
levels had a 1.5-fold greater risk of disease progression and a twofold
greater risk of dying, compared to patients with optimal vitamin D levels
after accounting for other patient factors associated with worse outcomes"
-
Green Tea Extract Shows Promise In Leukemia Trials - Science Daily,
5/26/09 - "We found not only that patients tolerated
the green tea extract at very high doses, but that many of them saw
regression to some degree of their chronic lymphocytic leukemia ... majority
of individuals who entered the study with enlarged lymph nodes saw a 50
percent or greater decline in their lymph node size" - See
green tea extract at Amazon.com.
-
Drinking Wine May Increase Survival Among Non-Hodgkin's Lymphoma Patients
- Science Daily, 4/21/09 - "those who drank wine had
a 76 percent five-year survival compared with 68 percent for non-wine
drinkers. Further research found five-year, disease-free survival was 70
percent among those who drank wine compared with 65 percent among non-wine
drinkers"
-
Grape Extracts May Be Effective Against Harmful Gut Bacteria - Science
Daily, 3/4/09 - "H. pylori is the bacterial agent
most commonly associated with peptic ulcers, gastritis, mucosa-associated
lymphoid tissue lymphoma, and gastric cancer ... The antibacterial effects
of extracts from red, white, black and muscadine grapes as well as the pure
compounds resveratrol, ellagic acid, and myricetin were tested for anti-H.
pylori activity using agar dilution, laser scanning microscopy and cell
proliferation. Following 24 hour treatment, results showed that muscadine
grape skin extract had the highest anti-H. pylori effect, followed by
muscadine grape synergy and seed extract. Additionally, two of the three
compounds, resveratrol and ellagic acid, also inhibited H. pylori" -
See
grape seed extract at Amazon.com
and
resveratrol products at Amazon.com.
-
Curcumin
induces cell-arrest and apoptosis in association with the inhibition of
constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma
cells - Int J Cancer. 2008 Apr 3 -
"Interestingly, curcumin caused cell cycle arrest in G2-M and a significant
reduction (80-97%) in H-RS cell viability. Furthermore, curcumin triggered
cell death by apoptosis, as evidenced by the activation of caspase-3 and
caspase-9, changes in nuclear morphology and phosphatidylserine
translocation. The above findings provide a mechanistic rationale for the
potential use of curcumin as a therapeutic agent for patients with HL"
- See
curcumin products at Amazon.com.
-
Vegetables- and antioxidant-related nutrients, genetic susceptibility, and
non-Hodgkin lymphoma risk - Cancer Causes Control. 2008 Jan 17 -
"For the GSTM3 3-base insertion and higher total
vegetable intake, the risk was 0.56 (0.35-0.92, p interaction = 0.03); for
GSTP1 A114V and higher cruciferous vegetable intake, the risk was 0.52
(0.34-0.81, p interaction = 0.02); for OGG1 S326C and higher daily zinc
intake, the risk was 0.71 (0.47-1.08, p interaction = 0.04) and for XRCC3
T241M and higher green leafy vegetable intake, the risk was 0.63"
-
Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin
lymphoma - Cancer Causes Control. 2007 Jul 25 -
"Our results suggest that the inverse association between UV exposure and
NHL risk may be mediated by the vitamin D pathway"
-
Carotenoids linked to lower risk of non-Hodgkin lymphoma - Nutra USA,
6/12/06 - "High daily intakes of the carotenoids
lutein and zeaxanthin, as well as vegetables in general, could reduce the
risk of non-Hodgkin lymphoma by almost 50 per cent"
-
Getting Some Sun May Fight Blood Cancer - WebMD, 3/31/04 -
"women and men who got the most sun exposure during
their off-work hours had the lowest risk of non-Hodgkin's lymphoma ... What
might be causing it? The obvious answer is that vitamin D synthesized in the
skin from sun exposure is causing this effect. There is increasing evidence
that vitamin D has protective effects against many cancers. The evidence for
colorectal cancer protection is pretty solid"
- Diet Linked to
Non-Hodgkin's Lymphoma - WebMD, 3/9/04 -
"if a person has a higher intake of animal protein,
they will have a higher risk of non-Hodgkin's lymphoma ... And people who
have a higher intake of saturated fat have an increased risk. On the other
hand, if you have higher-than-average intake of dietary fiber --
particularly if you frequently eat vegetables and fruits with a high fiber
content -- you have a reduced risk of non-Hodgkin's lymphoma"
-
What role,
if any, does Cox-2 inhibition play in the case of lymphoma? - Life
Extension Magazine, 1/02
-
Fish Oil
Slows Lymphoma - Life Extension Magazine, 9/00
Other News:
-
Dietary
patterns and the risk of non-Hodgkin lymphoma - Public Health Nutr. 2013
May 9:1-7 - "Population-based sample residing in
Nebraska from 1999 to 2002 ... Our results suggest that a dietary pattern
high in meats, fats and sweets may be associated with an increased risk of
NHL"
-
IMRT
improves outcomes in patients with extranodal lymphoma of the head and neck,
study suggests - Science Daily, 8/16/11
-
Vaccine increases disease-free survival for follicular lymphoma patients:
Study on personalized therapy may lead to a 'flood of new agents' -
Science Daily, 5/31/11
-
Household contact with pets and birds and risk of lymphoma - Cancer
Causes Control. 2010 Dec 14 - "Frequent contact with
birds was inversely associated with lymphoma, and particularly B-cell
non-Hodgkin lymphoma (odds ratio [OR] = 0.6, 95% confidence interval [95%
CI]: 0.4, 0.9). Contact with chickens accounted for this inverse
association, which was strongest for first contact occurring at age ≤8 years
(OR = 0.4, 95% CI: 0.2, 1.0). No association was observed when first contact
occurred at age 9 or older. Contact with any pets was inversely associated
with risk of diffuse large B-cell lymphoma (OR = 0.4, 95% CI: 0.2, 1.0), but
not other lymphoma subtypes"
-
Brentuximab Shows
"Amazing" Responses in Refractory Lymphoma - Medscape, 12/8/10
-
New
lymphoma therapy may be more effective with fewer side effects - Science
Daily, 11/3/10
-
Lymphoma and leukemia discovery may improve therapy - Science Daily,
11/1/10
-
New
lymphoma treatment shows promise in dogs - Science Daily, 9/7/10
-
Lifestyle factors significantly impact survival of non-Hodgkin's lymphoma
patients, study finds - Science Daily, 5/13/10
-
Personalized Lymphoma
Vaccine Is Granted Orphan Drug Status - Medscape, 1/11/10
-
Immunotherapy Demonstrates Long-term Success In Treating Lymphoma -
Science Daily, 10/31/09
-
Successful New Treatment For Hodgkin's Lymphoma, Reduces Long-term Risks
- Science Daily, 7/13/09
-
Anti-inflammatory Drugs May Defeat Treatment-resistant Type Of Cancer -
Science Daily, 6/24/09 - "The anti-inflammatory
drugs etanercept and infliximab, which are currently used to treat arthritis
and inflammatory bowel disease, work by suppressing TNFα, suggesting a new
way to curb the malignancy of this type of lymphoma ... The team tested the
idea in mice that had been injected with aggressive lymphoma cells and found
that nascent tumors shrank in six days"
-
New
Therapeutic Approach To Combat Lymphoma - Science Daily, 3/19/09
-
New
Therapy Prevents Dangerous Side Effect For Lymphoma Patients, Study Suggests
- Science Daily, 12/9/08
-
Intense Chemotherapy Wards Off Recurrence In Half Of Mantle Cell Lymphoma
Patients After Seven Years - Science Daily, 12/9/08
-
Hodgkin Lymphoma: New Characteristics Discovered; Cytokines Help Tumor Cells
Evade Immune System - Science Daily, 10/8/08
-
New
Treatment Approach Promising For Lymphoma Patients In Developing World -
Science Daily, 7/6/08
-
Watch-And-Wait Strategy
Appropriate in Many With Residual MALT Lymphoma - Medscape, 1/1/08
-
Mini-BMT: Non-Hodgkin's Lymphoma Cure? - WebMD, 12/10/07
-
A New Resource for Lymphoma Patients - Physician's Weekly, 10/15/07
-
Lymphoma Drug Bexxar Effective Over Long Term, Study Finds - Science
Daily, 6/4/07
-
Risk
Of Lymphoma Increases With Hepatitis C Virus Infection - Science Daily,
5/8/07
-
Promising Results For Patients With Aggressive, Recurrent Non-Hodgkin
Lymphoma Using New Oral Drug - Science Daily, 12/19/06
-
FDA Approves Velcade(R) (Bortezomib) for Injection for Aggressive Form of
Non-Hodgkin's Lymphoma - Doctor's Guide, 12/8/06
-
New Hope for Patients With Chronic Lymphocytic Leukemia - Doctor's
Guide, 12/5/06
-
Personalized Cancer Vaccine Improves Disease Free Survival - Doctor's
Guide, 10/20/06 - "administration of the BiovaxID™
anti-cancer vaccine formulation resulted in long-lasting remission in NHL
patients"
-
Allos Therapeutics Receives FDA Fast Track Designation for PDX for the
Treatment of T-cell Lymphoma - Doctor's Guide, 10/3/06
-
FDA Approves Two New Indications for Rituxan(R) (Rituximab) in Patients With
Non-Hodgkin's Lymphoma - Doctor's Guide, 9/30/06
-
Custom-Made Lymphoma Vaccine Promising - WebMD, 9/19/06
-
FDA Grants Orphan Drug Designation to Allos Therapeutics' Novel Antifolate
PDX (Pralatrexate) for Treatment of T-cell Lymphoma - Doctor's Guide,
7/26/06
-
One-Third of Patients With Mantle Cell Lymphoma Respond to Bortezomib
Treatment - Doctor's Guide, 6/6/06
-
Primary Intraocular Lymphoma Patients Respond to Methotrexate Therapy -
Doctor's Guide, 5/5/06
-
Pixantrone Combination Regimen Produces High Rates of Complete Remission for
Patients With Aggressive NHL Who Fail CHOP Therapy - Doctor's Guide,
3/22/06
-
FDA Approves Rituxan (Rituximab) Plus CHOP or Other Anthracycline-Based
Chemotherapy Regimens for First-Line Treatment of Diffuse Large B-cell
Non-Hodgkin's Lymphoma - Doctor's Guide, 2/13/06
-
BiovaxID Yields 89% Survival in Patients with Aggressive Non-Hodgkin's -
Doctor's Guide, 1/24/06
-
BiovaxID Produces Long Term Clinical Remission and 95% Overall Survival
- Doctor's Guide, 1/11/06
-
Zevalin Used in Abbreviated Chemotherapy Regimen Shows Efficacy for
Follicular Non-Hodgkin's Lymphoma - Doctor's Guide, 12/16/05
-
New Treatment Regimen May Improve Mantle Cell Lymphoma - Doctor's Guide,
12/14/05
-
Total Body Irradiation Followed by Autologous Stem Cell Transplantation Best
Option for Chemo-Resistant Hodgkin's Lymphoma - Doctor's Guide, 12/13/05
-
Age Makes Little Difference in Outcomes for Non-Hodgkin's Lymphoma Patients
Receiving Chemotherapy - Doctor's Guide, 12/12/05
-
PCBs, Furans May Factor In Risk Of Non-Hodgkin Lymphoma - Science Daily,
12/2/05
-
Addition of Pixantrone to Rituxan Therapy Significantly Prolongs Time to
Disease Progression and Improves the Overall Response Rate Compared to
Rituxan Alone in Relapsed or Refractory Indolent Lymphoma - Doctor's
Guide, 11/9/05
-
Yttrium 90 Ibritumomab Tiuxetan (Zevalin) as Effective in Older as in
Younger Non-Hodgkin's Lymphoma Patients - Doctor's Guide, 10/24/05
-
Treatment Advances For Lymphoma Have Reduced Deaths By 70% - Science
Daily, 10/21/05
-
Treatment Advances for Lymphoma Have Reduced Deaths By 70% - Doctor's
Guide, 10/20/05
-
Combination of Abbreviated Chemotherapy with Radioactive Monoclonal Antibody
Effective in Previously Untreated Non-Hodgkin 's Lymphoma - Doctor's
Guide, 9/9/05
-
Tositumomab and Iodine I-131 Tositumomab May Result in Prolonged Remission
in Low-Grade NHL - Medscape, 6/22/05
-
Positive Effects of Nuclear Medicine, 'Smart Drugs' Provide Hope for
Non-Hodgkin's Lymphoma Patients - Doctor's Guide, 6/21/05
-
High-Dose Methotrexate for Elderly Patients With Newly Diagnosed Primary
Central Nervous System Lymphoma - Doctor's Guide, 6/17/05
-
Addition of Rituximab to Combination Chemotherapy Improves Outcomes in
Advanced Stage Lymphoplasmocytoid/ic Immunocytoma - Doctor's Guide,
6/15/05
-
Yttrium-90 Ibritumomab Tiuxetan (Zevalin) Induces High Response Rates in
Previously Treated Patients With Diffuse Large B-Cell Lymphoma -
Doctor's Guide, 6/14/05
-
Limited Stage Follicular Lymphoma Might Be Curable: Presented at ICML -
Doctor's Guide, 6/13/05
-
Fludarabine Offers Option for First-Line Treatment of Chronic Lymphocytic
Lymphoma - Doctor's Guide, 6/10/05
-
Low-Dose Involved Field Radiotherapy Induces Rapid and Lasting Remissions
Without Significant Toxicity in B-Cell Lymphoma - Doctor's Guide,
6/10/05
-
New Regimen After Chemotherapy Improves Survival in Elderly Patients With
Diffuse Large-Cell Lymphoma - Doctor's Guide, 6/10/05
-
Pegylated Liposomal Doxorubicin (Caelyx)-Based Regimen Carries Less Cardiac
Toxicity: Presented at ESMO - Doctor's Guide, 6/9/05
-
Less Aggressive Regimen As Effective and Equally Tolerated as Standard
Treatment for Elderly Patients With Aggressive Non-Hodgkin's Lymphoma -
Doctor's Guide, 6/9/05
-
Large Study Shows Link Between Statin Use and Risk of Lymphoma -
Doctor's Guide, 6/9/05 -
"Use of statins is associated with a decrease in the
risk of developing any type of lymphoma"
-
Bortezomib Shows Promise in Treatment of Relapsed or Refractory Mantle Cell
Lymphoma - Doctor's Guide, 6/9/05
-
Rituximab Improves Outcomes in Patients With Diffuse Large B-Cell Lymphoma
- Doctor's Guide, 6/8/05
-
Rituximab Plus CVP Versus CVP Alone Improves Outcomes in First-Line
Treatment of Advanced Follicular Lymphoma - Doctor's Guide, 6/8/05
-
Yttrium-90 Ibritumomab Tiuxetan (Zevalin) Therapy With Rituximab Maintenance
Might Improve Outcomes in Patients With Low-Grade Follicular Lymphoma -
Doctor's Guide, 6/8/05
-
ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma -
N Engl J Med. 2005 Mar 24;352(12):1197-205
-
HuMax-CD4 (Zanolimumab) Shows Long-Lasting Responses in T-Cell Lymphoma
Patients - Doctor's Guide, 2/18/05
-
New Treatment Rivals Chemotherapy For Lymphoma, Study Finds - Science
Daily, 2/8/05
-
'Zapping' Cancer - CBS 2 Chicago, 2/3/05
- New Non-Hodgkin's
Lymphoma Drug Passes Hurdle - WebMD, 2/2/05
-
FDA Approves Expanded Indication for Bexxar (Tositumomab) in Non-Hodgkin's
Lymphoma - Doctor's Guide, 1/3/05
- New Therapeutic
Strategies for Non-Hodgkin's Lymphoma: An Expert Interview With Dr. Richard
Fisher - Medscape, 12/20/04
-
Breakthrough MabThera data now shows patients with indolent Non-Hodgkin's
Lymphoma can live longer - Doctor's Guide, 12/10/04
-
Bortezomib Combats Non-Hodgkin's Lymphomas - Doctor's Guide, 12/8/04
-
Rituximab Standard Therapy Effective for Many Non-Hodgkin's Lymphomas -
Doctor's Guide, 12/6/04
- Blood Test May
Reveal Lymphoma Dangers - WebMD, 11/17/04
-
FDA Grants Fast Track Status to Velcade (bortezomib) for Injection for
Relapsed and Refractory Mantle Cell Lymphoma - Doctor's Guide, 11/3/04
-
Half of Patients With Aggressive Non-Hodgkin's Lymphoma May Not Receive Full
Recommended Dose of Chemotherapy - Doctor's Guide, 9/21/04
-
Prolonged Rituximab Shows Promise for Follicular Lymphoma and Mantle Cell
Leukemia - Doctor's Guide, 9/16/04
-
Maintenance Rituximab May Prolong Progression-Free Survival and Response
Rates in Previously Untreated Follicular Lymphoma - Doctor's Guide,
9/15/04
-
Rituximab Provides Additional Benefits to Initial Chemotherapy in Aggressive
Non-Hodgkin's Lymphoma - Doctor's Guide, 9/15/04
-
Rituximab Adds Efficacy to Aggressive Chemotherapy Regimen for HIV Patients
With Non-Hodgkin's Lymphoma - Doctor's Guide, 9/15/04
-
Addition of Rituximab Improves Outcomes Over Standard Immunochemotherapy in
Follicular Lymphoma - Doctor's Guide, 9/15/04
-
Single-agent Rituximab May Prove Effective and Safe for Chronic
Thrombocytopenia Purpura - Doctor's Guide, 9/15/04
-
Rituximab Provides Effective Rescue Treatment for Patients With Refractory
Immune Thrombocytopenia Purpura - Doctor's Guide, 9/14/04
-
EPOCH Regimen Plus Rituximab Effective and Well Tolerated for Aggressive
Diffuse Large B-cell and Mantle Cell Lymphoma - Doctor's Guide, 9/14/04
-
Rituximab Improves Efficacy of Fludarabine-Based Therapy in Chronic
Lymphocytic Leukemia - Doctor's Guide, 9/14/04
-
Improved Overall Survival Rates Seen With Combined Immunochemotherapy
Approach in Indolent Non-Hodgkin's Lymphoma - Doctor's Guide, 9/13/04
-
Intrathecal Administration of Rituximab Shows Promise for Central Nervous
System Lymphoma - Doctor's Guide, 9/13/04
-
Rituximab and High-Dose Chemotherapy and Autologous Stem Cell
Transplantation Improves Survival in Mantle Cell Lymphoma - Doctor's
Guide, 9/13/04
-
Rituximab Plus CHOP Improves Outcomes in Young, Low-risk Patients With
Non-Hodgkin's Lymphoma - Doctor's Guide, 9/13/04
-
Addition of Rituximab to Standard Chemotherapy Regimen Improves Survival in
Aggressive Non-Hodgkin's Lymphoma - Doctor's Guide, 9/13/04
-
HuMax-CD4, Treatment for Mycosis Fungoides, Receives FDA Orphan Drug
Designation - Doctor's Guide, 8/23/04
-
Treatment Strategies in Patients With Cutaneous T-Cell Lymphomas -
Doctor's Guide, 7/1/04
-
Rituximab, a New Advance in the Treatment of Non-Hodgkin Lymphoma -
Doctor's Guide, 7/1/04
-
Fludarabine Plus Mitoxantrone With Rituximab May be More Effective
Front-Line Treatment for Follicular Lymphoma than CHOP - Doctor's Guide,
6/23/04
-
Rituximab Plus Thalidomide Demonstrates Marked Anti-Tumour Activity in
Patients With Mantle Cell Lymphoma - Doctor's Guide, 6/23/04
-
High Response Rates Seen With Fludarabine, Cyclophosphamide and Mitoxantrone
in Previously Untreated Advanced Stage Follicular Lymphoma - Doctor's
Guide, 6/15/04
-
Rituximab/Thalidomide Combination Appears Safe, Effective in Cases of
Relapsed or Refractory Mantel Cell Lymphoma - Doctor's Guide, 6/14/04
-
Rituximab Equally Effective in Young and Old Patients With Diffuse Large
B-cell Non-Hodgkin Lymphoma - Doctor's Guide, 6/10/04
-
Relapsed Lymphoma Patients Respond to Gemcitabine-Based Salvage Regimen
- Doctor's Guide, 6/8/04
-
More Than Half of High-Risk Lymphoma Patients Treated With Suboptimal
Regimens - Doctor's Guide, 6/7/04
-
Relapsed Mantle-Cell Lymphoma Responds to Rituximab and Thalidomide Therapy
- Doctor's Guide, 6/7/04
-
Rituximab Plus CHOP Effective as First Line Therapy for Manatle Cell
Lymphoma and as Maintenance Therapy for Indolent Lymphoma - Doctor's
Guide, 6/7/04
-
Fludarabine/Mitoxantrone Combination Appears Safe, Effective As Frontline
and Salvage Treatment for Nongastrointestinal Mucosa-Associated Lymphoid
Tissue Lymphoma - Doctor's Guide, 5/27/04
-
High Remission Rates Reported in Patients Receiving Campath-1H for
Refractory Leukaemic Low-Grade Non-Hodgkin's Lymphoma - Doctor's Guide,
5/6/04
-
Pamidronate May Reduce New Vertebral Fractures, Loss of Bone Mineral Density
in During Chemotherapy for Malignant Lymphoma - Doctor's Guide, 4/26/04
-
Methotrexate Implicated in Lymphoma Development in Patient With Rheumatoid
Arthritis - Doctor's Guide, 4/19/04
-
Rituximab May Produce Complete Remission of Splenic Marginal Zone Lymphoma
When Chemotherapy Gives Partial Response - Doctor's Guide, 4/19/04
-
Fludarabine/Mitoxantrone/Dexamethasone Therapy Effective for in Elderly
Patients with Advanced, Low-Grade Non-Hodgkin's Lymphomas - Doctor's
Guide, 4/15/04
-
Salvage Therapy With Rituximab-EPOCH Appears Safe, Effective in Relapsed or
Refractory B-Cell Lymphomas - Doctor's Guide, 4/15/04
-
Acetaminophen May Increase NHL Risk in Women - Doctor's Guide, 3/31/04
-
Thalidomide May Not be Effective As Single-Agent Therapy for Recurrent
Non-Hodgkin Lymphoma and Hodgkin Disease - Doctor's Guide, 3/29/04
-
High-Dose Chemotherapy Plus Hematopoietic Stem-Cell Infusion Appears More
Effective Than Standard Chemotherapy for Aggressive Non-Hodgkin?s Lymphoma
- Doctor's Guide, 3/26/04
- High-Dose
Chemotherapy With SCT Helpful in Aggressive Lymphoma - Medscape, 3/24/04
-
Fine-Needle Cytology With Immunophenotyping Accurate in Diagnosing Lymphomas
- Doctor's Guide, 3/23/04
-
Extension of Rituximab Treatment May Improve Event-Free Survival in Patients
with Follicular Lymphoma - Doctor's Guide, 3/23/04
-
Rituximab Use Inserted Into New Lymphoma Guidelines - Doctor's Guide,
3/15/04
-
Etoposide Improves Standard Chemotherapy in Patients with Aggressive
Non-Hodgkin´s Lymphoma - Doctor's Guide, 3/9/04
-
Rituximab Adjunct May Improve Response in Patients with Relapsed Diffuse
Large B-cell Lymphoma - Doctor's Guide, 2/11/04
-
Interferon-alpha/Isotretinoin Combination Therapy May Have Anti-tumour
Activity for Advanced and Refractory Lymphomas - Doctor's Guide, 2/10/04
-
Anthracycline-Containing Regimens Recommended as Standard Treatment for
Advanced Follicular Lymphoma - Doctor's Guide, 2/4/04
-
Clinical Remission Achieved In Case Of Adult T Cell Leukaemia/Lymphoma Using
Multiple-Agent Therapy With Denileukin Diftitox - Doctor's Guide,
1/30/04
-
Long-Term Efficacy With Cyclophosphamide, Epirubicin, Vincristine and
Prednisone for Intermediate or High-Grade Non-Hodgkin's Lymphoma -
Doctor's Guide, 1/29/04
-
Mitoguazone Added to Low-Dose CHOP is Safe and Effective Treatment for
AIDS-Related Non-Hodgkin's Lymphoma - Doctor's Guide, 1/22/04
-
90Y Ibritumomab Tiuxetan Safe and Effective Therapy for Many Types of
Non-Hodgkin's Lymphoma - Doctor's Guide, 1/21/04
-
Doxorubicin- and Pirarubicin-Based Chemotherapy Regimens Equally Effective
in Treating Non-Hodgkin's Lymphoma - Doctor's Guide, 12/23/03
-
"Bexxar" Regimen Induces Complete Response in Patients with Follicular
Non-Hodgkin's Lymphoma - Doctor's Guide, 12/18/03
-
Rituximab Increases Time to Progression for Lymphoma Patients - Doctor's
Guide, 12/16/03
-
New Analysis Confirms Most Complete Remissions in Follicular non-Hodgkin's
Lymphoma Persist for Years Following Single Treatment with Bexxar
(Tositumomab and Iodine I 131 Tositumomab)
- Doctor's Guide, 12/15/03
-
Rituximab Prolongs Chemo Response in Non-Hodgkin's Lymphoma - Doctor's
Guide, 12/11/03
-
First Line Intensive Chemotherapy Followed by Transplantation May Improve
Survival Chances of Patients With High Risk Follicular Lymphoma -
Doctor's Guide, 12/10/03
-
Treatment With Autologous Stem-Cell Rescue In Peripheral T-Cell Lymphoma
Offers Results Similar To B-Cell Lymphoma - Doctor's Guide, 12/10/03
- Rituximab Increases
Time to Progression for Lymphoma Patients - Medscape, 12/9/03
-
Registry Demonstrates Benefit of Added Rituximab for Diffuse Large B-Cell
Lymphoma - Doctor's Guide, 12/9/03
-
Fludarabine May Place Patients At Risk Of Hepatitis B From Virus
Reactivation - Doctor's Guide, 12/4/03
-
Comparable Survival Between Surgery and Surgery Plus Chemotherapy for
Localised Gastric Diffuse Large B-Cell Lymphomas - Doctor's Guide,
12/3/03
-
Methotrexate Induction Therapy Followed by High-Dose Chemotherapy with
Autologous Stem Cell Rescue May Cause Less Neurotoxicity for Primary CNS
Lymphoma Patients - Doctor's Guide, 11/27/03
-
Combination Cyclophosphamide/Mitoxantrone/Rituximab Regimen Potentially
Safe, Effective Therapy for Indolent Lymphoma - Doctor's Guide, 11/14/03
-
Improved Response with Rituximab Use in Patients with Non-Hodgkin's Lymphoma
- Doctor's Guide, 11/3/03
-
Combination of Platinum Derived Chemotherapy and Rituximab Demonstrates
Significant Activity in Diffuse Large B-Cell Lymphoma Patients -
Doctor's Guide, 10/31/03
-
Addition of Rituximab to Chemotherapy Regimen May Increase Complete
Remission Rate in Patients With Diffuse Large B-Cell Lymphoma - Doctor's
Guide, 10/23/03
-
Routine Evaluation of the Stomach Recommended for Mucosa-Associated Lymphoid
Tissue Lymphoma Patients - Doctor's Guide, 10/1/03
-
Expert Overview of Gastrointestinal Lymphoma - Doctor's Guide, 9/29/03
-
Epoetin Beta Treatment During Aggressive Sequential Salvage Chemotherapy
Lowers Transfusion Needs, Raises Haemoglobin in Relapsed Lymphoma Patients
- Doctor's Guide, 8/27/03
-
Phase II Results Demonstrate Long Lasting Tumour Responses For Pixantrone
(BBR 2778) In Relapsed Aggressive Non-Hodgkin's Lymphoma - Doctor's
Guide, 8/26/03
-
Rituximab May Offer Effective Treatment for Low Grade Duodenal Lymphoma
- Doctor's Guide, 8/22/03
-
Combination Rituximab, Granulocyte-Colony Stimulating Factor Therapy May
Extend Remission Duration In Non-Hodgkin's Lymphoma - Doctor's Guide,
8/18/03
-
Delaying Chemotherapy Until Disease Progression Does Not Alter Overall
Survival in Advanced-Stage Non-Hodgkin Lymphoma - Doctor's Guide,
8/18/03
-
CHOP Superior to CNOP in Elderly Patients With Aggressive Non-Hodgkin
Lymphoma - Doctor's Guide, 8/5/03
-
Chemotherapy Alone Reduces Delayed Toxicity Risk On Elderly CNS Lymphoma
Patients - Doctor's Guide, 7/31/03
-
Response to Rituximab Predicted by Polymorphism - Doctor's Guide,
7/15/03
-
FDA Approves Bexxar (Tositumomab/Iodine I 131 Tositumomab) For Use In
Treatment-Resistant Cancer Of The Lymphatic System - Doctor's Guide,
7/3/03
-
High-Dose Methotrexate, Lower-Dose Radiation May Benefit Patients With
Primary Central Nervous System Lymphoma - Doctor's Guide, 7/2/03
-
Serum Selenium Concentration Predicts Prognosis In Aggressive Non-Hodgkin's
Lymphoma - Doctor's Guide, 7/2/03
-
FDA Approves Bexxar in Patients With Follicular Non-Hodgkin's Lymphoma -
Doctor's Guide, 6/30/03
-
Haematopoietic Stem Cell Transplant Should Not Be First-Line Therapy for
Non-Hodgkin's Lymphoma - Doctor's Guide, 6/25/03
-
Baseline Anaemia, Older Age Increase Risk of in Non-Hodgkin's Lymphoma -
Doctor's Guide, 6/19/03
-
Low White Blood Cell Count and Refractory Disease Are Predictive of Poor
Response to Mobilisation in Lymphoma - Doctor's Guide, 6/18/03
-
Darbepoetin alfa (Aranesp) Treats Chemotherapy-induced Anaemia in Lymphatic
Cancers - Doctor's Guide, 6/16/03
-
Combined Modality Therapy Continues To Confer High Rates Of Disease Control,
Survival For Stage I-II Indolent Non-Hodgkin's Lymphoma - Doctor's
Guide, 6/16/03
-
Combined Modality Treatment Significantly Increases Survival Rate of Primary
Lymphoma Of Bone - Doctor's Guide, 6/6/03
-
CNOP Plus Rituximab Safe, Effective In Indolent Non-Hodgkin's Lymphoma -
Doctor's Guide, 6/5/03
-
Zevalin (Yttrium90-Iribitumomab Tiuxetan) Shows Long-Term Efficacy in
Non-Hodgkin's Lymphoma - Doctor's Guide, 6/3/03
-
Long-Term Survival For Aggressive Non-Hodgkin's Lymphoma Patients Improved
With MabThera Plus Chemotherapy - Doctor's Guide, 6/2/03
-
Long-Term Survival Can Be Improved Without Cyclophosphamide For Localised
B-Cell Non-Hodgkin's Lymphoma - Doctor's Guide, 5/28/03
-
Radioimmunotherapy May Be Safe, Effective Alternative To Treat Advanced
Follicular Non-Hodgkin's Lymphoma - Doctor's Guide, 5/28/03
-
Prognostic Factors Identify Children With Hodgkin's Disease At High-Risk Of
Relapse After Combined-Modality Therapy - Doctor's Guide, 5/27/03
-
Fludarabine/Mitoxantrone Combo Safe And Effective For Advanced-Stage,
Low-Grade Lymphoma - Doctor's Guide, 5/26/03
-
First-Line, Maintenance Rituximab Therapy Effective And Safe In Chronic
Lymphocytic Leukaemia Or Small Lymphocytic Lymphoma Patients - Doctor's
Guide, 5/21/03
-
Prognostic Factors, Treatment for Children with Primary Mediastinal Large
B-Cell Lymphoma With Sclerosis - Doctor's Guide, 5/20/03
-
Hypothyroidism Linked To Bexarotene For Lymphoma - Doctor's Guide,
4/22/03
-
Long-Term Remission Achieved In Mantle-Cell Lymphoma - Doctor's Guide,
4/4/03
-
High Dose Methotrexate Has Modest Toxicity Among CNS Lymphoma Cohort -
Doctor's Guide, 3/26/03
-
Factors That Predict Survival Identified In Localized Aggressive
Non-Hodgkin's Lymphoma - Doctor's Guide, 2/25/03
- Pegfilgrastim Given
Once Per Cycle Best After Lymphoma Chemotherapy - Medscape, 2/20/03
-
New B-ALPS Prognostic Index Useful In Head And Neck Lymphomas - Doctor's
Guide, 1/7/03
-
Bexxar (Tositumomab/Iodine I 131 Tositumomab) Receives Strong Support From
FDA Advisory Panel - Doctor's Guide, 12/18/02
-
Durable Responses With Bexxar (Tositumomab) In Transformed Non Hodgkin's
Lymphoma - Doctor's Guide, 12/16/02
-
Prolonged Rituximab Treatment Improves Event-Free Survival and Response
Duration in Follicular Lymphoma - Doctor's Guide, 12/13/02
-
Long-Term Survival Good with Chemotherapy Plus Low-Dose Extended-Field
Irradiation - Doctor's Guide, 12/11/02
-
Addition of Rituximab to Combination Chemotherapy Significantly Improves
Treatment of Mantle Cell Lymphomas - Doctor's Guide, 12/10/02
-
Rituximab Improves Responses in Elderly Patients with Advanced Follicular
Lymphoma - Doctor's Guide, 12/9/02
-
Durable Responses Reported with Single Dose of Tositumomab and Iodine I-131
Tositumomab (Bexxar) in Relapsed, Refractory Low-grade Non-Hodgkin's
Lymphoma - Doctor's Guide, 12/9/02
-
Rasburicase Reduces Uric Acid Levels in Aggressive Lymphoma Patients -
Doctor's Guide, 12/9/02
-
Chemotherapy or Chemotherapy/Radiotherapy for Primary Bone Lymphomas -
Doctor's Guide, 11/5/02
-
Bexarotene Effective For Treatment Of Cutaneous T-Cell Lymphoma -
Doctor's Guide, 11/1/02
- Rituximab Effective
in Indolent Non-Hodgkin's Lymphoma - Medscape, 10/30/02
-
New Diagnostic Tool For T-Cell Lymphoma Faster, More Sensitive -
Doctor's Guide, 10/14/02
-
Combined Immunomodulatory Therapy Benefits Patients With Cutaneous T-Cell
Lymphoma - Doctor's Guide, 9/16/02
- Intrathecal
Methotrexate Reduces Recurrence in NHL - Medscape, 8/2/02
-
Tobacco may a be cause of non-Hodgkin's lymphoma - USA Today, 7/29/02
-
Sequential Fludarabine And CNOP In Follicular Lymphoma - Doctor's Guide,
7/29/02
-
French Researchers Offer New Guidelines for Mantle Cell Lymphoma -
Doctor's Guide, 6/21/02
-
Two Intensive Chemotherapy Regimens Improve Quality Of Life In Elderly
Patients With Diffuse Large Cell Lymphoma - Doctor's Guide, 6/20/02
-
Molecular Profiling: Future Aid To Some Lymphoma Patients? - Doctor's
Guide, 6/20/02
-
Radiotherapy Well Tolerated, Effective against Stage I/II Mucosa-associated
Lymphoid Tissue Lymphomas - Doctor's Guide, 6/20/02
-
Combination of Fludarabine and CVP Effective in Elderly Patients with
Advanced Low-Grade Lymphomas - Doctor's Guide, 6/20/02
-
Improved Timing Reduces Risks of Involved-Field Radiotherapy in Lymphoma
Patients - Doctor's Guide, 6/19/02
-
High-Dose Chemotherapy plus Autologous Stem Cell Transplantation no Better
than Intensified Chemotherapy against Diffuse Large Cell Lymphoma -
Doctor's Guide, 6/19/02
-
ACVBP Superior to CHOP plus Radiotherapy in Low-Risk Localized Aggressive
Non-Hodgkin's Lymphoma - Doctor's Guide, 6/19/02
-
Dose-Escalated CHOP Therapy plus Etoposide Effective against Aggressive
Non-Hodgkin's Lymphoma - Doctor's Guide, 6/19/02
-
Bexxar Found to be Effective against Follicular Lymphoma - Doctor's
Guide, 6/19/02
- High-Dose
Radioimmunotherapy Best for Mantle Cell Lymphoma - Medscape, 6/18/02
-
Quantification of Circulating t(14;18)+ Cells Predicts Response to Rituximab
Therapy in Follicular Lymphoma Patients - Doctor's Guide, 6/18/02
-
Effect of Rituximab May Be Augmented by Interferon Alfa-2a in Indolent
Lymphomas - Doctor's Guide, 6/18/02
-
Fludarabine, Cyclophosphamide and Mitoxantrone Safe and Effective against
Follicular Lymphoma - Doctor's Guide, 6/18/02
-
Modified Chemotherapy Regimen with Mitozantrone Safe and Effective in
Elderly Patients with Aggressive Non-Hodgkin's Lymphoma - Doctor's
Guide, 6/18/02
-
Bendamustine Better than Cyclophosphamide in Advanced Low Grade
Non-Hodgkin's Lymphomas - Doctor's Guide, 6/16/02
-
Prognostic Factors for Relapse and Transformation of Indolent Follicular
Lymphoma - Doctor's Guide, 6/16/02
-
New Evidence that Rituximab May Delay Relapse in Lymphatic Cancer -
Doctor's Guide, 6/16/02
-
Extended Rituximab Treatment Shows Promise in Waldenström's
Macroglobulinemia - Doctor's Guide, 6/13/02
-
Ibritumomab Tiuxetan Safe and Effective in Transformed B-cell Non-Hodgkin's
Lymphoma - Doctor's Guide, 5/23/02
-
Rituximab Subsequent to Zevalin Viable Treatment for Non-Hodgkin's Lymphoma
- Doctor's Guide, 5/23/02
- Zevalin Helpful in
Low-Grade B-Cell Non-Hodgkin's Lymphoma - Medscape, 5/20/02
-
New Radioimmunotherapy Drug Proves Highly Effective For Killing Off B Cell
Non-Hodgkin's Lymphoma - Doctor's Guide, 5/13/02
-
High-Dose Total Body Radiotherapy with Stem Cell Transplantation Is
Effective Treatment for Some Patients with Chemo-Resistant Lymphoma -
Doctor's Guide, 5/2/02
-
Irradiation of Intraocular Lymphoma Urged in Patients With Primary CNS
Lymphomas and Ocular Disease - Doctor's Guide, 4/29/02
-
Fewer Than Half Of Mucosa-Associated Lymphoid Tissue Lymphoma Patients Stay
In Molecular Remission Following Anti-H Pylori Therapy - Doctor's Guide,
4/11/02
-
Significant Association Found With Simian Virus 40 And Non-Hodgkin Lymphoma
- Doctor's Guide, 3/12/02
-
Mucus In Hair May Indicate Lymphoma - Doctor's Guide, 3/8/02
-
Follicular Mycosis Fungoides Is A Distinct Type Of Cutaneous T Cell Lymphoma
- Doctor's Guide, 2/26/02
-
Bexarotene Gel Safe And Effective For Early-Stage Cutaneous T-Cell Lymphoma
- Doctor's Guide, 2/25/02
-
FDA Approves Zevalin (ibritumomab tiuxetan) for Treatment of Non-Hodgkin's
Lymphoma - Doctor's Guide, 2/20/02
-
FDA Approves Anti-Cancer Cell Drug [Zevalin] - Intelihealth, 2/20/02
- More on Epstein-Barr
Virus in Hodgkin's Lymphoma - Medscape, 2/02
- Rituxan (Rituximab) plus
Standard Chemotherapy Proves More Effective Than Standard Chemo Alone in
Aggressive Non-Hodgkin’s Lymphoma - Doctor's Guide, 1/31/02
-
New Drug Mix A Significant Advance For Older Lymphoma Patients -
Doctor's Guide, 1/25/02
- Fludarabine and
Mitoxantrone Followed by Rituximab Demonstrate Efficacy as First-Line
Treatment for Follicular Lymphoma - Doctor's Guide, 12/12/01
- CHOP Plus Rituximab
Increases Disease-Free Survival Interval in Newly Diagnosed Follicular
Non-Hodgkin’s Lymphoma - Doctor's Guide, 12/12/01
- Bexxar Antibody Treatment
Increases Response Rate in Refractory or Relapsed Low-Grade Non-Hodgkin’s
Lymphoma - Doctor's Guide, 12/12/01
- Bexxar (Tositumomab and
Iodine (I)-131-Tositumomab) Plus CHOP Improves Best Result in Newly
Diagnosed Follicular Non-Hodgkin’s Lymphoma - Doctor's Guide, 12/12/01
- Long-Term Data Still
Favour CHOP + Radiation Therapy for Low Risk Aggressive Non-Hodgkin’s
Lymphoma - Doctor's Guide, 12/11/01
- Bexxar (Tositumomab/Iodine
I 131 Tositumomab) Promising In Treatment Of Non-Hodgkin's Lymphoma -
Doctor's Guide, 12/11/01
- Rituximab Plus CHOP Has
Advantage Versus CHOP Alone in Elderly Patients with Diffuse Large B-cell
Lymphoma - Doctor's Guide, 12/11/01
- Adding Etoposide to CHOP
Improves Results in Younger Low-Risk Non-Hodgkin’s Lymphoma Patients -
Doctor's Guide, 12/11/01
- Sequential Fludarabine
Followed by CNOP Reduces Toxicity and Maintains Activity in Low-Grade
Follicular Lymphoma - Doctor's Guide, 12/11/00
- High Response Rates Seen
in Advanced Non-Hodgkin’s Lymphoma Following Consolidation with Rituximab
- Doctor's Guide, 12/11/01
- Intensified Biweekly CHOP
Chemotherapy Proves Highly Effective In Aggressive Non-Hodgkin's Lymphoma
- Doctor's Guide, 12/10/01
- Mega-CHOP Safe and
Effective for Aggressive Non-Hodgkin's Lymphoma - Doctor's Guide,
12/10/01
- Rituximab Improves
Response Rates in Relapsed or Refractory B-Cell Lymphoma - Doctor's
Guide, 12/10/01
-
Dexamethasone, Cytarabine And Oxaliplatin Salvage Therapy For Non-Hodgkin's
Lymphoma - Doctor's Guide, 11/12/01
- Radiation Doesn't Help
Hodgkin's Lymphoma Patients Who Are In Remission - Doctor's Guide,
11/6/01
- Experimental Histone
Deacetylase Inhibitor Appears Effective In T-Cell Lymphomas - Doctor's
Guide, 11/1/01
- Bexxar (Tositumomab/Iodine
I 131Tositumomab) Demonstrates Improved Response in Chemo-Refractory
Non-Hodgkin's Lymphoma - Doctor's Guide, 10/2/01
- BBR 2778 Shows Promise In
Non-Hodgkin's Lymphoma - Doctor's Guide, 10/1/01
-
Severe psoriasis linked to lymphoma, skin cancer - USA Today, 6/14/01
- Patient-Optimized Dosing
With Bexxar (Tositumomab and Iodine I-131 Tositumomab) Reduces Risk Of
Over-/Under-Dosing In Non-Hodgkin's Lymphoma - Doctor's Guide, 5/15/01
- Rituximab Therapy Induces
Complete Remissions In Post-Transplant Lymphoproliferative Disorders -
Doctor's Guide, 5/15/01
- MabThera (Rituximab) Plus
Standard Chemotherapy Improves Survival Rates in Non-Hodgkin’s Lymphoma
- Doctor's Guide, 5/14/01
- Anti-CD20 Antibody
Rituximab May Have A Role In Primary Central Nervous System Lymphoma
Treatment - Doctor's Guide, 4/24/01
- MabThera (Rituximab) With
Stem Cell And Bone Marrow Transplant Improves Outcome In Non-Hodgkin’s
Lymphoma - Doctor's Guide, 3/26/01
- Anti-Apoptosis Proteins
May Predict Prognosis Of Primary CNS Lymphoma - Doctor's Guide, 3/6/01
-
Alternative High-Dose Preparatives Needed For Non-Hodgkin's Lymphoma -
Doctor's Guide, 2/2/01
- Zevalin (Ibritumomab
Tiuxetan) Improves Efficacy Of Rituxan (Rituxumab) In Non-Hodgkin's Lymphoma
- Doctor's Guide, 12/5/00
- Mitoxantrone/Fludarabine
Followed By Rituximab Effective In Low-Grade Non-Hodgkin's Lymphoma -
Doctor's Guide, 12/5/00
- Recombinant Tumor-Derived
Protein Stimulates Specific Immune-Response Against Non-Hodgkin's Lymphoma
- Doctor's Guide, 12/5/00
-
Drug combination improves lymphoma survival rates - CNN, 12/4/00
- Low-dose Radiotherapy
Successful For Mucosa-associated Lymphoid-tissue Lymphomas - Doctor's
Guide, 10/26/00
- Rituximab Promising In
Relapsed Non-Hodgkin’s Lymphoma After Autologous Stem-Cell Transplantation
- Doctor's Guide, 7/18/00
- New Combination Effective
For Non-Hodgkin's Lymphoma - Doctor's Guide, 7/18/00
- New Treatment Strategies
Available For Hodgkin’s Disease And Non-Hodgkin’s Lymphoma - Doctor's
Guide, 7/17/00
- Epratuzumab Promising
Against Non-Hodgkin's Lymphoma - Doctor's Guide, 5/23/00
- Bexxar Highly Effective
First-Line Treatment for Non-Hodgkin's Lymphoma - Doctor's Guide,
5/23/00
-
Antibodies Show Promise Vs. Cancer - Intelihealth, 5/23/00
- Antisense drug G3139 for
non-Hodgkin's lymphoma reduces target protein levels - Doctor's Guide,
5/5/00
- Onco TCS Shrinks Lymphoma
Tumors By At Least 50 Percent In Non-Hodgkin’s Lymphoma Relapses -
Doctor's Guide, 12/6/99
- Rituxan, In Combination,
Appears Effective For Non-Hodgkin's Lymphoma - Doctor's Guide, 12/6/99
- Bexxar Effective As
Combination Therapy For Non-Hodgkin’s Lymphoma - Doctor's Guide, 12/6/99
- Bexxar Halts Progression
Of Non-Hodgkin's Lymphoma, Study Shows - Doctor's Guide, 6/7/99
- Rituxan And Fludarabine
Effective For NHL Treatment - Doctor's Guide, 5/19/99
- FDA Approves Ontak For
Cutaneous T-Cell Lymphoma - Doctor's Guide, 2/5/99
- New Treatment Combo For
Non-Hodgkin's Lymphoma - Doctor's Guide, 1/15/99
- Coulter Initiates Expanded
Access Program For Bexxar For Non-Hodgkin’s Lymphoma - Doctor's Guide,
9/29/98
- Immunosuppressive Treatment
May Help Rheumatoid Arthritis Patients Avoid Lymphomas - Doctor's Guide,
7/17/98
- Some Cancers Come Back
Because Chemo Is Stopped Too Soon, Say Researchers - Doctor's Guide,
6/8/98
- First New Drug for
Non-Hodgkin's Lymphoma in Decade Cleared In U.S. - Doctor's Guide,
11/26/97
- FDA Clears Intron A For
Non-Hodgkin's Lymphoma - Doctor's Guide, 11/10/97
- PCB Exposure May Increase
Lymphoma Risk - Doctor's Guide, 7/25/97
- Antibodies May Help Fight
Treatment Resistant Non-Hodgkin's Lymphoma - Doctor's Guide, 6/4/97
- Bexxar Effective As
First-Line Therapy For Non-Hodgkin's Lymphoma - Doctor's Guide, 5/20/97
Related Searches:
Related Sites:
71129
|
|